The Lancet Rheumatology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order
Journals package 3months
    http://medilib.ir
  • Duration of Time : 93 Day
  • :
  • Price : 100$
  • Special Price : 50$
Order

Patient-initiated follow-up: leave no one behind

doi : 10.1016/S2665-9913(24)00343-6

Volume 6, Issue 12e811December 2024

Buy The Package and View The Article Online


Prevention of seronegative rheumatoid arthritis: an entity of its own

doi : 10.1016/S2665-9913(24)00226-1

Buy The Package and View The Article Online


Proximod as a potential therapy for rheumatoid arthritis

doi : 10.1016/S2665-9913(24)00237-6

Buy The Package and View The Article Online


Digital remote monitoring in rheumatology: using health economics to support wider adoption

doi : 10.1016/S2665-9913(24)00306-0

Buy The Package and View The Article Online



Palliative care in patients with rheumatic diseases

doi : 10.1016/S2665-9913(24)00238-8

Buy The Package and View The Article Online


Efficacy of combined immunomodulators in preventing uveitis relapses in patients with Behçet's disease on corticosteroids

doi : 10.1016/S2665-9913(24)00300-X

Buy The Package and View The Article Online


Efficacy of combined immunomodulators in preventing uveitis relapses in patients with Behçet's disease on corticosteroids – Authors' reply

doi : 10.1016/S2665-9913(24)00301-1

Buy The Package and View The Article Online


Correction to Lancet Rheumatol 2024; published Online Sept 18, 2024. https://doi.org/10.1016/S2665-9913(24)00220-0

doi : 10.1016/S2665-9913(24)00313-8

Buy The Package and View The Article Online



Una Makris: What matters to older patients, matters most to her

doi : 10.1016/S2665-9913(24)00342-4

Buy The Package and View The Article Online


Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial

doi : 10.1016/S2665-9913(24)00196-6

Buy The Package and View The Article Online


Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial

doi : 10.1016/S2665-9913(24)00199-1

Buy The Package and View The Article Online


Patient-initiated follow-up supported by asynchronous telemedicine versus usual care in spondyloarthritis (TeleSpA-study): a randomised controlled trial of clinical and cost-effectiveness

doi : 10.1016/S2665-9913(24)00229-7

Buy The Package and View The Article Online


Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial

doi : 10.1016/S2665-9913(24)00223-6

Buy The Package and View The Article Online


Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities

doi : 10.1016/S2665-9913(24)00190-5

Buy The Package and View The Article Online


Frailty and rheumatic diseases: evidence to date and lessons learned

doi : 10.1016/S2665-9913(24)00191-7

Buy The Package and View The Article Online


Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist

doi : 10.1016/S2665-9913(24)00230-3

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?